Medicine
Cilostazol 50 mg tablet
Cilostazol 50 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store cilostazol tablets at 25°C (77°F), excursions permitted from 15°C to…
Key facts
- Active ingredient (INN)
- Cilostazol
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets, 30 tablets, 1000 tablets and 7 more
- Manufacturers
- Aurobindo PharmaIndiaApotexAvPAKBryant Ranch PrepackChartwell RXDirect_RxSlate Run PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store cilostazol tablets at 25°C (77°F), excursions permitted from 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC23 Cilostazol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 November 2005
- Identifiers
- RxCUI 242461, 242462DailyMed set ID aec462c8-e225-f520-cae5-80049151c0ff, f728395c-684c-4087-a389-c323dbcb72dd, ceac1ae3-c343-28ca-c083-b748d21a15e6 +5NDC 50268-176, 63629-8796, 60505-2521 +5Application ANDA077030, ANDA077027, ANDA077208 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet in 1 bottle | 84386-002-60 | Aurobindo PharmaIndia | 3 September 2026 |
| 60 tablet in 1 bottle | 60505-2521-1 | Apotex | 18 October 2011 |
| 30 tablet in 1 bottle | 60505-2521-3 | Apotex | 18 October 2011 |
| 1000 tablet in 1 bottle | 60505-2521-8 | Apotex | 18 October 2011 |
| 60 tablet in 1 bottle | 62135-983-60 | Chartwell RX | 27 August 2025 |
| 60 tablet in 1 bottle | 70436-156-06 | Slate Run Pharmaceuticals | 16 April 2021 |
| 60 tablet in 1 bottle | 0093-2065-06 | Teva Pharmaceuticals | 24 April 2012 |
| 50 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 50268-176-15 | AvPAK | 18 October 2016 |
| 60 tablet in 1 bottle | 63629-8796-1 | Bryant Ranch Prepack | 30 August 2022 |
| 60 tablet in 1 bottle | 72189-116-60 | direct rx | 2 December 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 January 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cilostazol
Clinical summary
Cilostazol is a phosphodiesterase 3 inhibitor indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. It is available as tablets for oral use. MedsAcross supplies Cilostazol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CilostazolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CILOSTAZOL prescribing information (Aurobindo Pharma) · U.S. National Library of Medicine, DailyMed
Need Cilostazol 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.